Consano Bio Raises $15M

Consano Bio raises $15M Series A+ led by Conviction.

Participants in this funding round include various investors eager to support advancements in healthcare.

Consano Bio develops therapeutics designed to address serious, painful orthopedic conditions. The company is led by CEO Andrew Hall.

Company	Consano Bio
Amount	$15M
Founders	Andrew Hall, Conviction Andrew Hall
Sectors	Biotechnology